DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice-Reference-Cited by-同舟云学术

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

Published:2000-11-01 Issue:9 Volume:165 Page:5133-5142
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Rovero Stefania,Amici Augusto,Carlo Emma Di,Bei Roberto,Nanni Patrizia,Quaglino Elena,Porcedda Paola,Boggio Katia,Smorlesi Arianna,Lollini Pier-Luigi,Landuzzi Lorena,Colombo Mario P.,Giovarelli Mirella,Musiani Piero,Forni Guido

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells

2. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

3. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

4. Three dimensional structure of the transmembrane region of the proto-oncogenic and oncogenic forms of the neu protein.

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice;International Journal of Molecular Sciences;2024-06-06

2. Correlative multiscale 3D imaging of mouse primary and metastatic tumors by sequential light sheet and confocal fluorescence microscopy;2024-05-17

3. Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models;PLOS ONE;2024-03-18

4. PIM kinase inhibitor AZD1208 in conjunction with Th1 cytokines potentiate death of breast cancer cells in vitro while also maximizing suppression of tumor growth in vivo when combined with immunotherapy;Cellular Immunology;2024-03

5. Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer;British Journal of Pharmacology;2024-01-26